Clinical Trial Update: Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating granulocyte-colony stimulating factor as an optimizing therapy for pediatric liver transplantation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Malnutrition

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Liver Cirrhosis, Severe Malnutrition | Phase 3 | Status: COMPLETED